Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions*

Insulin-like growth factor-binding protein-3 and -5 (IGFBP-3 and -5) have been shown to bind insulin-like growth factor-I and -II (IGF-I and -II) with high affinity. Previous studies have proposed that the N-terminal region of IGFBP-5 contains a hydrophobic patch between residues 49 and 74 that is required for high affinity binding. These studies were undertaken to determine if mutagenesis of several of these residues resulted in a reduction of the affinity of IGFBP-3 and -5 for IGF-I. Substitutions for residues 68, 69, 70, 73, and 74 in IGFBP-5 (changing one charged residue, Lys68, to a neutral one and the four hydrophobic residues to nonhydrophobic residues) resulted in an ∼1000-fold reduction in the affinity of IGFBP-5 for IGF-I. Substitutions for homologous residues in IGFBP-3 also resulted in a >1000-fold reduction in affinity. The physiologic consequence of this reduction was that IGFBP-3 and -5 became very weak inhibitors of IGF-I-stimulated cell migration and DNA synthesis. Likewise, the ability of IGFBP-5 to inhibit IGF-I-stimulated receptor phosphorylation was attenuated. These changes did not appear to be because of alterations in protein folding induced by mutagenesis, because the IGFBP-5 mutant was fully susceptible to proteolytic cleavage by a specific IGFBP-5 protease. In summary, residues 68, 69, 70, 73, and 74 in IGFBP-5 appear to be critical for high affinity binding to IGF-I. Homologous residues in IGFBP-3 are also required, suggesting that they form a similar binding pocket and that for both proteins these residues form an important component of the core binding site. The availability of these mutants will make it possible to determine if there are direct, non-IGF-I-dependent effects of IGFBP-3 and -5 on cellular physiologic processes in cell types that secrete IGF-I.

• Publication year

  2000

• Venue

  Journal of Biological Chemistry

• Publication date

  2000-06-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/JBC.M000070200PMID 10766744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.

  1999cited by this paper
• The IGF system : molecular biology, physiology, and clinical applications

  1999cited by this paper
• Isolation and characterization of circulating 13‐kDa C‐terminal fragments of human insulin‐like growth factor binding protein‐5

  1998cited by this paper
• Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4*

  1998cited by this paper
• Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain*

  1998cited by this paper
• Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions

  1998cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit*

  1998cited by this paper
• Membrane-associated Insulin-like Growth Factor-binding Protein-3 Inhibits Insulin-like Growth Factor-I-induced Insulin-like Growth Factor-I Receptor Signaling in Ishikawa Endometrial Cancer Cells*

  1997cited by this paper
• Insulin-like growth factor binding proteins and their role in controlling IGF actions.

  1997cited by this paper
• Insulin-like growth factor-II participates in the biphasic effect of a gonadotropin-releasing hormone agonist on ovarian cancer cell growth.

  1997cited by this paper
• Characterization of truncated insulin-like growth factor-binding protein-2 in human milk.

  1997cited by this paper
• Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• Binding Sites and Binding Properties of Binary and Ternary Complexes of Insulin-like Growth Factor-II (IGF-II), IGF-binding Protein-3, and Acid-labile Subunit*

  1997cited by this paper
• Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.

  1997cited by this paper
• Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin (*)

  1996cited by this paper
• The Insulin-like Growth Factor (IGF) Binding Site of Bovine Insulin-like Growth Factor Binding Protein-2 (bIGFBP-2) Probed by Iodination*

  1996cited by this paper
• Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3*

  1996cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 Proteolysis (*)

  1995cited by this paper
• Insulin-like growth factor binding protein proteolysis in bone cell models.

  1995cited by this paper
• Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4

  1995cited by this paper
• Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells.

  1995cited by this paper
• Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions.

  1995cited by this paper
• A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3.

  1995cited by this paper
• The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.

  1995cited by this paper
• Solution structure of human insulin‐like growth factor II; recognition sites for receptors and binding proteins.

  1994cited by this paper
• Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5.

  1994cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.

  1993cited by this paper
• Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study.

  1993cited by this paper
• Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells.

  1993cited by this paper
• IGF binding proteins and their functions

  1993cited by this paper
• Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I

  1993cited by this paper
• Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion.

  1992cited by this paper
• Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.

  1992cited by this paper
• Insulin‐like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)

  1990cited by this paper
• The ontogeny and regulation of a 31,000 molecular weight insulin-like growth factor-binding protein in fetal porcine plasma and sera.

  1988cited by this paper
• Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors.

  1988cited by this paper

• Heterologous expression and biological characteristics of UGPases from Lactobacillus acidophilus

  2022cites this paper
• Biological effects and regulation of IGFBP5 in breast cancer

  2022cites this paper
• Response to Different Oxygen Partial Pressures and Evolution Analysis of Apoptosis-Related Genes in Plateau Zokor (Myospalax baileyi)

  2022cites this paper
• The Aspects of CCN Protein Family on Breast Cancer

  2021cites this paper
• Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia

  2021cites this paper
• IGFBP-rP1, a strongly conserved member of the androgenic hormone signalling pathway in Isopoda.

  2019cites this paper
• In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1

  2018cites this paper
• Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas

  2018cites this paper
• Sexual development in the male Eastern Spiny Lobster (Sagmariasus verreauxi): the sex determination mechanism and ongoing regulation of sexual differentiation

  2017cites this paper
• Altered regulation of adipogenesis with respect to disease processes

  2017cites this paper
• Understanding Insulin Endocrinology in Decapod Crustacea: Molecular Modelling Characterization of an Insulin-Binding Protein and Insulin-Like Peptides in the Eastern Spiny Lobster, Sagmariasus verreauxi

  2017cites this paper
• Lamprey IGF-Binding Protein-3 Has IGF-Dependent and -Independent Actions

  2017cites this paper
• Dual roles of CCN proteins in breast cancer progression

  2016cites this paper
• Chapter 21 – Insulin-Like Growth Factor-1 and Its Binding Proteins∗

  2016cites this paper
• Investigation of alanine mutations affecting insulin-like growth factor (IGF) I binding to IGF binding proteins

  2015cites this paper
• Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells

  2015cites this paper
• The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction

  2015cites this paper
• IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF

  2015cites this paper
• Regulation of IGFBP-1 Phosphorylation in Hypoxia Via mTOR Signaling

  2014cites this paper
• Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

  2014cites this paper
• IGF binding proteins in cancer: mechanistic and clinical insights

  2014cites this paper
• Sensibilization of dendritic cell-like antigen presenting cells by low-molecular weight drugs : molecular characterization and function of the dendritic cell specific organic anion transporting polypeptide OATP5A1

  2013cites this paper
• The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.

  2013cites this paper
• Structural and functional analysis of the amphioxus IGFBP gene uncovers ancient origin of IGF-independent functions.

  2013cites this paper
• A Crayfish Insulin-like-binding Protein

  2013cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2013cites this paper
• Insulin-Like Growth Factor (IGF) Binding Protein 2 Functions Coordinately with Receptor Protein Tyrosine Phosphatase β and the IGF-I Receptor To Regulate IGF-I-Stimulated Signaling

  2012cites this paper
• Insulin-Like Growth Factor Binding Proteins: A Structural Perspective

  2012cites this paper
• a structural perspective,

  2011cites this paper
• New Insights from Studying Insulin-like Growth Factor (IGF)-Binding Protein-5 in Zebrafish : Role of IGF Signaling in Epithelial Calcium Absorption.

  2011cites this paper
• Structure and function of the iron-regulatory protein, repulsive guidance molecule c / hemojuvelin

  2011cites this paper
• Defining the Disulfide Bonds of Insulin-like Growth Factor-binding Protein-5 by Tandem Mass Spectrometry with Electron Transfer Dissociation and Collision-induced Dissociation*

  2011influential citation
• IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos

  2011influential citation
• Normal and Aberrant Growth

  2011cites this paper
• Insulin-Like Growth Factor System in HIV/AIDS: A Structure Based Approach to the Design of New Therapeutics

  2011cites this paper
• Biological characterization and structure based prediction of insulin-like growth factor binding protein-5.

  2010cites this paper
• CCN6 regulates breast cancer growth and invasion through modulation of IGF signaling and epithelial to mesenchymal transition

  2010cites this paper
• Insulin-Like Growth Factor-1 and Its Binding Proteins

  2010cites this paper
• Association Between Two Functional Polymorphisms of Insulin-Like Growth Factor Binding Protein 3 and Colorectal Cancer Risk in a Chinese Population

  2009cites this paper
• Serum complexes of insulin‐like growth factor‐1 modulate skeletal integrity and carbohydrate metabolism

  2009cites this paper
• The emerging role of CCN6 in breast cancer invasion.

  2009cites this paper
• binding protein-5 (Igfbp5) in vivo

  2009cites this paper
• Unraveling insulin-like growth factor binding protein-3 actions in human disease.

  2009cites this paper
• IGF‐independent effects of insulin‐like growth factor binding protein‐5 (Igfbp5) in vivo

  2009cites this paper
• Rexinoid-induced Expression of IGFBP-6 Requires RARβ-dependent Permissive Cooperation of Retinoid Receptors and AP-1*

  2009cites this paper
• Insulin-Like Growth Factor Signaling during Myogenesis.

  2009influential citation
• MOLECULAR REGULATION OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-5 BY SIGNALING MOLECULES DOWNSTREAM OF THE IGF-I RECEPTOR IN MAMMARY EPITHELIAL CELLS

  2009cites this paper
• IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop

  2008cites this paper
• Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.

  2008cites this paper
• Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-α

  2008influential citation
• Apoptosis and autophagy in involuting bovine mammary gland.

  2008cites this paper
• The role of IGFBP3 functional polymorphisms in the risk of gastric cancer in a high-risk Chinese population

  2008cites this paper
• Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions.

  2008cites this paper
• Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.

  2008cites this paper
• IGFBP5 is a potential regulator of craniofacial skeletogenesis

  2008cites this paper
• Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.

  2008cites this paper
• Characterization of insulin-related peptides and their relation to molt and metabolism in the shrimp Litopenaeus vannamei.

  2008cites this paper
• Molecular regulation of insulin-like growth factor binding protein-3 and its role in ribotoxic stress-induced apoptosis

  2008cites this paper
• Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer

  2008cites this paper
• Characterization of Insulin-Like Peptides and Their Relation to Molt and Metabolism of the Shrimp Litopenaeus vannamei

  2008cites this paper
• Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study

  2007cites this paper
• Growth hormone suppresses the expression of IGFBP-5, and promotes the IGF-I-induced phosphorylation of Akt in bovine mammary epithelial cells.

  2007cites this paper
• Insulin-Like Growth Factor-Binding Protein 3

  2007cites this paper
• Promotion of Cancer Cell Migration

  2007cites this paper
• Engineering a Synthetic Extra-Cellular Matrix for In Vitro Cartilage Tissue Production

  2007cites this paper
• Insulin-like growth factor binding protein-3 : structure and function

  2007cites this paper
• Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor?

  2007cites this paper
• CCN6 (WISP3) as a New Regulator of the Epithelial Phenotype in Breast Cancer

  2007cites this paper
• Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5.

  2007cites this paper
• Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling.

  2007cites this paper
• Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.

  2006cites this paper
• Insulin-like Growth Factor-binding Protein-5 Activates Plasminogen by Interaction with Tissue Plasminogen Activator, Independently of Its Ability to Bind to Plasminogen Activator Inhibitor-1, Insulin-like Growth Factor-I, or Heparin*

  2006cites this paper
• Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity*

  2006cites this paper
• Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

  2006cites this paper
• Insulin-Like Growth Factor Binding Protein-2: Contributions of the C-Terminal Domain to Insulin-Like Growth Factor-1 Binding

  2006influential citation
• Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.

  2006cites this paper
• Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

  2006cites this paper
• The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3.

  2006cites this paper
• Insulin-like Growth Factor-I and Its Binding Proteins: Regulation of Secretion and Mechanism of Action at the Receptor Level

  2006cites this paper
• Functional and structural studies on the signal transduction proteins involved in tumorigenesis: insulin-like growth factor binding proteins (IGFBPs), integrin linked kinase (ILK), and 14-3-3σ

  2006influential citation
• The insulin-like growth factor system : Effects of circulating proteases

  2005cites this paper
• Structural basis for the regulation of insulin-like growth factors (IGFs) by IGF binding proteins (IGFBPs)

  2005cites this paper
• Segmental Igfbp5 expression is specifically associated with the bent structure of zigzag hairs.

  2005cites this paper
• Biochemical Studies on IGF and IGF-Binding Proteins Interactions & Structural Investigations on the SH3 Domain of Crk-associated Tyrosine Kinase Substrate p130cas (CAS)

  2005cites this paper
• Insulin‐like growth factor binding protein‐5 (IGFBP‐5) interacts with thrombospondin‐1 to induce negative regulatory effects on IGF‐I actions

  2005influential citation
• Insulin-like Growth Factor Polymorphisms and Colorectal Cancer Risk

  2005cites this paper
• Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors

  2005cites this paper
• Disruption of protein–protein interactions: Towards new targets for chemotherapy

  2005cites this paper
• Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells.

  2005cites this paper
• IGF-binding proteins--the pieces are falling into place.

  2005cites this paper
• Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

  2004cites this paper
• Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo.

  2004cites this paper
• Fibronectin Binds Insulin-like Growth Factor-binding Protein 5 and Abolishes Its Ligand-dependent Action on Cell Migration*

  2004cites this paper
• Role of N- and C-terminal Residues of Insulin-like Growth Factor (IGF)-binding Protein-3 in Regulating IGF Complex Formation and Receptor Activation*

  2004cites this paper
• Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells

  2004cites this paper
• C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II.

  2004cites this paper
• Transgenic mice expressing selected insulin-like growth factor-binding protein-5 fragments do not exhibit enhanced bone formation.

  2004cites this paper
• Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.

  2004cites this paper
• Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function

  2004influential citation
• C-terminal domain of insulin-like growth factor binding protein-6: structure and interaction with insulin-like growth factor-II

  2004cites this paper